U.S., Europe, Japan Look to Speed Up Drug Reviews

See allHide authors and affiliations

Science  17 Mar 2000:
Vol. 287, Issue 5460, pp. 1958-1959
DOI: 10.1126/science.287.5460.1958

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Drug companies are hoping to save time and money by submitting the same safety and efficacy data to regulators in each of the three leading global markets. This fall, if all goes well, officials from the United States, Europe, and Japan will agree on a common drug review application form in hope of speeding the delivery of new treatments and, perhaps, lowering the cost to consumers.